<DOC>
	<DOC>NCT00247650</DOC>
	<brief_summary>This study is to measure the extent of tumor shrinkage when Letrozole and Zoledronic Acid are given before surgery to newly diagnosed post-menopausal women with early breast cancer</brief_summary>
	<brief_title>Comparison Study of Letrozole Alone or Letrozole With Zoledronic Acid in Early Breast Cancer, Neoadjuvant Therapy</brief_title>
	<detailed_description />
	<mesh_term>Breast Neoplasms</mesh_term>
	<mesh_term>Zoledronic acid</mesh_term>
	<mesh_term>Diphosphonates</mesh_term>
	<mesh_term>Letrozole</mesh_term>
	<criteria>Inclusion Criteria Postmenopausal women Newly diagnosed with non metastatic breast cancer Candidate for mastectomy or breastconserving surgery Exclusion Criteria Patients with invasive tumors Patients receiving anticancer treatment Patients who have undergone surgery Other protocoldefined exclusion criteria may apply.</criteria>
	<gender>Female</gender>
	<minimum_age>65 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2009</verification_date>
	<keyword>neoadjuvant, postmenopausal women, breast cancer, hormonal therapy, bisphosphonate</keyword>
</DOC>